Preliminary report of improved sleep quality in patients with dry eye disease after initiation of topical therapy

Neuropsychiatric Disease and Treatment

Volumn 12, Issue , 2016, Pages 329-337

  Ayaki, Masahiko ^a   Toda, Ikuko ^b   Tachi, Naoko ^c   Negishi, Kazuno ^a   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Ophthalmology   (Japan)

^c Shinseikai Toyama Hospital   (Japan)

Author keywords

Anxiety; Depression; Dry eye; Liaison psychiatry; Sleep

Indexed keywords

DIQUAFOSOL; EYE DROPS; HYALURONIC ACID; RAMELTEON; REBAMIPIDE; SEDATIVE AGENT; UNCLASSIFIED DRUG; YOKUKANSAN EXTRACT;

ADULT; ARTICLE; BLUE LIGHT SHIELD EYEWEAR; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORRELATION ANALYSIS; DEVICE THERAPY; DISEASE SEVERITY; DRY EYE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPTICAL INSTRUMENTATION; PATIENT ASSESSMENT; PHOTOPHOBIA; PHOTOTHERAPY; PITTSBURGH SLEEP QUALITY INDEX; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP QUALITY; SLEEP THERAPY; TREATMENT RESPONSE; WEARABLE BLUE LIGHT THERAPY LAMP;

EID: 84958526627     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S94648     Document Type: Article

References (28)

1. Moseley MJ, Fouladi M, Jones HS, Tobin MJ. Sleep disturbance and blindness. Lancet. 1996;348:1514–1515.
2. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108:1893–1900.
3. Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol. 2012;96(6):821–825.
4. Kong XM, Zhu WQ, Hong JX, Sun XH. Is glaucoma comprehension associated with psychological disturbance and vision-related quality of life for patients with glaucoma? A cross-sectional study. BMJ Open. 2014;4(5):e004632.
5. Ishii K, Kabata T, Oshika T. The impact of cataract surgery on cognitive impairment and depressive mental status in elderly patients. Am J Ophthalmol. 2008;146:404–409.
6. Labbé A, Wang YX, Jie Y, Baudouin C, Jonas JB, Xu L. Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. Br J Ophthalmol. 2013;97:1399–1403.
7. Wen W, Wu Y, Chen Y, et al. Dry eye disease in patients with depressive and anxiety disorders in Shanghai. Cornea. 2012;31:686–692.
8. Kessel L, Siganos G, Jørgensen T, Larsen M. Sleep disturbances are related to decreased transmission of blue light to the retina caused by lens yellowing. Sleep. 2011;34(9):1215–1219.
9. Agorastos A, Skevas C, Matthaei M, et al. Depression, anxiety, and disturbed sleep in glaucoma. J Neuropsychiatry Clin Neurosci. 2013;25(3):205–213.
10. Gracitelli CP, Duque-Chica GL, Moura AL, et al. A positive association between intrinsically photosensitive retinal ganglion cells and retinal nerve fiber layer thinning in glaucoma. Invest Ophthalmol Vis Sci. 2014;55(12):7997–8005.
11. Ayaki M, Kawashima M, Negishi K, Tsubota K. High prevalence of sleep and mood disorders in dry eye patients: survey of 1,000 eye clinic visitors. Neuropsychiatr Dis Treat. 2015;11:889–894.
12. Ayaki M, Negishi K, Suzukamo Y, Tsubota K. Color of intra-ocular lens and cataract opacity type are prognostic determinants for health indices after photoreceptive restoration by surgery. Rejuvenation Res. 2015;18(2):145–152.
13. Alexander I, Cuthbertson FM, Ratnarajan G, et al. Impact of cataract surgery on sleep in patients receiving either ultraviolet blocking or blue-shielding intraocular lens implants. Invest Ophthalmol Vis Sci. 2014;55:4999–5004.
14. Shimmura S, Ono M, Shinozaki K, Toda I, et al. Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol. 1995;79(11):1007–1011.
15. Tauber J, Davitt WF, Bokosky JE, et al. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Cornea. 2004;23(8):784–792.
16. Kinoshita S, Awamura S, Oshiden K, Nakamichi N, Suzuki H, Yokoi N; Rebamipide Ophthalmic Suspension Phase II Study Group. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study. Ophthalmology. 2012;119(12):2471–2478.
17. Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep. 2013;1:51–57.
18. Smith GC. The future of consultation-liaison psychiatry. Aust N Z J Psychiatry. 2003;37(2):150–159.
19. Ogawa A, Nouno J, Shirai Y, et al. Availability of psychiatric consultation-liaison services as an integral component of palliative care programs at Japanese cancer hospitals. Jpn J Clin Oncol. 2012;42(1):42–52.
20. Shimazaki J, Tsubota K, Kinoshita S, Ohashi Y. Definition and diagnosis of dry eye 2006. Atarashii Ganka. 2007;24:181–184. [In Japanese.].
21. Uchino Y, Uchino M, Dogru M, Ward S, Yokoi N, Tsubota K. Changes in dry eye diagnostic status following implementation of revised Japanese dry eye diagnostic criteria. Jpn J Ophthalmol. 2012;56(1):8–13.
22. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
23. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.
24. Suzukamo Y, Oshika T, Yuzawa M, et al. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual Life Outcomes. 2005;3:65.
25. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4:97–110.
26. Sack RA, Beaton A, Sathe S, Morris C, Willcox M, Bogart B. Towards a closed eye model of the pre-ocular tear layer. Prog Retin Eye Res. 2000;19(6):649–668.
27. Latkany RL, Lock B, Speaker M. Nocturnal lagophthalmos: an overview and classification. Ocul Surf. 2006;4(1):44–53.
28. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23(8):762–770.